Zheng Ying, Li Xue-Gang, Wang Qiu-Zhen, Ma Ai-Guo, Bygbjerg Ib Christian, Sun Yong-Ye, Li Yong, Zheng Ming-Ci, Wang Xi
Institute of Human Nutrition, Medical College of Qingdao University, Qingdao 266021, PR China.
Institute of Human Nutrition, Medical College of Qingdao University, Qingdao 266021, PR China.
Asian Pac J Trop Med. 2014 Feb;7(2):130-5. doi: 10.1016/S1995-7645(14)60008-0.
To investigate whether there is an association between diameter of bacille Calmette-Guérin (BCG) scars and effect of purified protein derivative (PPD) reaction and to determine whether vitamin A (VA) combined vitamin D (VD) supplementation influences the immune response to BCG revaccinated in Chinese infants.
A cross-section and 3-month community-randomised trial was conducted. A total of 5 629 infants at 3, 6 and 12 months of age in Junan County of China were examined for BCG scar formation. Then, 597 revaccinated infants were randomly assigned to supplementation (n=307) and control (n=290) groups. The supplementation group were daily assigned to 1 500 IU VA and 500 IU VD for 3 months. Then all infants were subjected to skin test with PPD.
The diameter of BCG scars was positively correlated with diameter of skin indurations of PPD (r=0.17, P<0.05) in the 5 629 infants. The rate of positive response to PPD was higher in the supplementation group than in the control group (96.1% versus 89.7%, P<0.05, prevalence ratio 1.07, 95% CI 1.02-1.12). The prevalence ratio of PPD response for the supplementation group compared with that for the control group was 1.07 (95% CI 1.01-1.13) for the males and 1.08 (95% CI 1.00-1.17) for the females. For the supplementation group, the males got larger tuberculin induration than the females [(0.73±0.21) cm versus (0.67±0.20) cm, P<0.05) after intervention.
The diameter of BCG scars was effectively correlated with PPD response, which indicates BCG scar formation may be an useful tool to evaluate the effect of tuberculosis prevention. VA combined VD supplementation may play an immuno-regulatory role in BCG revaccination. This may contribute to the prevention of childhood tuberculosis.
探讨卡介苗(BCG)瘢痕直径与纯化蛋白衍生物(PPD)反应效果之间是否存在关联,并确定补充维生素A(VA)联合维生素D(VD)是否会影响中国婴儿对BCG复种的免疫反应。
进行了一项横断面研究和为期3个月的社区随机试验。对中国莒南县5629名3、6和12月龄婴儿的BCG瘢痕形成情况进行检查。然后,将597名复种疫苗的婴儿随机分为补充组(n = 307)和对照组(n = 290)。补充组每天给予1500 IU VA和500 IU VD,持续3个月。然后所有婴儿接受PPD皮肤试验。
在5629名婴儿中,BCG瘢痕直径与PPD皮肤硬结直径呈正相关(r = 0.17,P < 0.05)。补充组PPD阳性反应率高于对照组(96.1%对89.7%,P < 0.05,患病率比1.07,95%CI 1.02 - 1.12)。补充组与对照组相比,男性PPD反应的患病率比为1.07(95%CI 1.01 - 1.13),女性为1.08(95%CI 1.00 - 1.17)。干预后,补充组男性的结核菌素硬结大于女性[(0.73±0.21)cm对(0.67±0.20)cm,P < 0.05]。
BCG瘢痕直径与PPD反应有效相关,这表明BCG瘢痕形成可能是评估结核病预防效果的有用工具。补充VA联合VD可能在BCG复种中发挥免疫调节作用。这可能有助于预防儿童结核病。